 Occurrence neoplasia patients rheumatoid arthritis DMARD Registry Rheumatoid Arthritis Azathioprine Registry Steering Committee Rheumatoid Arthritis Azathioprine Registry RAAR safety azathioprine AZA disease agents DMARD treatment RA yearly followup past years malignant conditions DMARD adult patients RA Incidence density ratios IDR standardized morbidity ratios SMR cancer risk cancers SMR CI men SMR CI women SMR CI age IDR study population age sex SMR lymphoproliferative disorders myeloma CI SMR lung cancer CI general population patients RA DMARD therapy increased risk malignancy lymphoproliferative disorders RAAR important prospective technique assessment neoplasia risk type duration DMARD therapy